Oct 2026· Journal of Oral Microbiology· Vol 18· 0 citations· 42 references
Medicine
TL;DR
The oral microbiome was generally not prospectively associated with postmenopausal breast cancer in a US population and results suggested previous findings may reflect reverse causation.
Abstract
Abstract Introduction Breast cancer is the most frequently diagnosed cancer among women worldwide. Some case-control studies have reported associations between the oral microbiome and breast cancer, but the temporality of the association remains unclear. Therefore, we examined this association prospectively in the NIH-AARP Diet and Health Study. Methods In 2005, oral wash samples were collected from a subset of the NIH-AARP cohort. We identified 318 women who developed breast cancer after collection and 318 controls, incidence-density matched on age at collection, race/ethnicity and smoking. DNA was extracted using the DNeasy PowerSoil Pro Kit, followed by shotgun metagenomic sequencing. Conditional logistic regression was used to calculate the odds ratios (OR) for associations between alpha- and beta-diversity and species- and gene-level metrics with breast cancer risk, adjusting for potential confounders. Results Cases developed breast cancer on average 3.4 years after sample collection. Overall, the majority of the microbial metrics, including species and genes, showed largely null associations with the exception of Pielou's evenness (OR = 0.82; 95% CI = 0.70–0.95). When stratified by time to diagnosis, the inverse association with Pielou's evenness was only detected among women diagnosed within 2 years (29% of cases). In this subgroup, some previously reported associations, like the inverse association with the presence of Treponema (OR = 0.37; 95% CI = 0.17–0.78), were replicated. Null associations were predominantly observed for cases diagnosed more than 2 years after sample collection. Conclusions The oral microbiome was generally not prospectively associated with postmenopausal breast cancer in a US population and results suggested previous findings may reflect reverse causation.
BACKGROUND
Breastfeeding reduces ovarian cancer risk, but the underlying biological mechanisms remain unclear.
METHODS
We examined the association between a previously reported metabolite-based breastfeeding score with incident epithelial ovarian cancer risk in case-control studies nested within the Nurses' Health St...
J. Mongiovi, N. Prince, J. A. Pacheco et al.· JNCI Cancer Spectrum· 0 citations
It is shown that people who are diagnosed with cancer after microbiome sampling have microbiome alterations like those found in diagnosed cancer cases, albeit to a lower degree, across the four populations studied, indicating that the microbiome may evolve towards the one found in cancer well before cancer is diagnosed...
G. Vitali, J. Bjork, O. Kambur et al.· medRxiv· 0 citations
BCa and inherited genetic susceptibility jointly contribute to increased risk of multiple common diseases, supporting the integration of genetic risk stratification into survivorship care.
Annabelle Ashworth, Zhu-Qing Shi, Huy Tran et al.· JNCI Cancer Spectrum· 0 citations
Breast cancer is the leading cause of diagnosed cancer cases in Iraq, making it the leading cause of cancer-related death among Iraqi women. BCs are characterized by genetic heterogeneity and complexity because of the overlap of numerous genes. Therefore, it is important to study genetic variants that increase the risk...
G. M. Khalaf· Natural Resources for Human...· 0 citations
BACKGROUND
The role of systemic inflammation in postmenopausal breast carcinogenesis remains unclear. Using a case-cohort study within the Melbourne Collaborative Cohort Study, we estimated the effects of circulating inflammatory biomarkers on the risk of postmenopausal oestrogen receptor (ER)-positive breast cancer....
Frances E. M. Albers, C. Swain, S. G. Dashti et al.· British Journal of Cancer· 0 citations
Dietary MUFA density was associated with an elevation in CRC risk and analyses based on food frequency questionnaires differed from these estimates for breast cancer, but tended to agree for CRC.
Ross L. Prentice, A. Aragaki, Johanna W. Lampe et al.· American Journal of Clinical...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.